Emergent BioSolutions Statistics
Total Valuation
EBS has a market cap or net worth of $262.45 million. The enterprise value is $844.75 million.
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025, after market close.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EBS has 54.34 million shares outstanding. The number of shares has increased by 3.52% in one year.
| Current Share Class | 54.34M |
| Shares Outstanding | 54.34M |
| Shares Change (YoY) | +3.52% |
| Shares Change (QoQ) | -2.52% |
| Owned by Insiders (%) | 2.54% |
| Owned by Institutions (%) | 64.02% |
| Float | 52.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 69.82 |
| PS Ratio | 0.26 |
| Forward PS | 0.27 |
| PB Ratio | 0.58 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.49 |
| P/OCF Ratio | 4.57 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 15.82, with an EV/FCF ratio of 23.60.
| EV / Earnings | n/a |
| EV / Sales | 0.81 |
| EV / EBITDA | 15.82 |
| EV / EBIT | n/a |
| EV / FCF | 23.60 |
Financial Position
The company has a current ratio of 3.69, with a Debt / Equity ratio of 1.40.
| Current Ratio | 3.69 |
| Quick Ratio | 1.56 |
| Debt / Equity | 1.40 |
| Debt / EBITDA | 12.66 |
| Debt / FCF | 18.89 |
| Interest Coverage | -0.74 |
Financial Efficiency
Return on equity (ROE) is -33.67% and return on invested capital (ROIC) is -2.43%.
| Return on Equity (ROE) | -33.67% |
| Return on Assets (ROA) | -2.03% |
| Return on Invested Capital (ROIC) | -2.43% |
| Return on Capital Employed (ROCE) | -4.25% |
| Revenue Per Employee | $1.16M |
| Profits Per Employee | -$211,778 |
| Employee Count | 900 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 2.09 |
Taxes
In the past 12 months, EBS has paid $47.70 million in taxes.
| Income Tax | 47.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +123.61% in the last 52 weeks. The beta is 2.15, so EBS's price volatility has been higher than the market average.
| Beta (5Y) | 2.15 |
| 52-Week Price Change | +123.61% |
| 50-Day Moving Average | 7.62 |
| 200-Day Moving Average | 8.70 |
| Relative Strength Index (RSI) | 33.12 |
| Average Volume (20 Days) | 1,295,105 |
Short Selling Information
The latest short interest is 6.95 million, so 12.79% of the outstanding shares have been sold short.
| Short Interest | 6.95M |
| Short Previous Month | 8.23M |
| Short % of Shares Out | 12.79% |
| Short % of Float | 13.12% |
| Short Ratio (days to cover) | 5.21 |
Income Statement
In the last 12 months, EBS had revenue of $1.04 billion and -$190.60 million in losses. Loss per share was -$3.60.
| Revenue | 1.04B |
| Gross Profit | 375.40M |
| Operating Income | -52.20M |
| Pretax Income | -578.10M |
| Net Income | -190.60M |
| EBITDA | 53.40M |
| EBIT | -52.20M |
| Loss Per Share | -$3.60 |
Full Income StatementBalance Sheet
The company has $99.50 million in cash and $676.10 million in debt, giving a net cash position of -$576.60 million or -$10.61 per share.
| Cash & Cash Equivalents | 99.50M |
| Total Debt | 676.10M |
| Net Cash | -576.60M |
| Net Cash Per Share | -$10.61 |
| Equity (Book Value) | 482.80M |
| Book Value Per Share | 8.89 |
| Working Capital | 436.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $58.70 million and capital expenditures -$22.90 million, giving a free cash flow of $35.80 million.
| Operating Cash Flow | 58.70M |
| Capital Expenditures | -22.90M |
| Free Cash Flow | 35.80M |
| FCF Per Share | $0.66 |
Full Cash Flow StatementMargins
Gross margin is 35.97%, with operating and profit margins of -5.00% and -18.26%.
| Gross Margin | 35.97% |
| Operating Margin | -5.00% |
| Pretax Margin | -13.69% |
| Profit Margin | -18.26% |
| EBITDA Margin | 5.12% |
| EBIT Margin | -5.00% |
| FCF Margin | 3.43% |
Dividends & Yields
EBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.52% |
| Shareholder Yield | -3.52% |
| Earnings Yield | -71.08% |
| FCF Yield | 13.35% |
Dividend DetailsAnalyst Forecast
The average price target for EBS is $14.33, which is 196.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.33 |
| Price Target Difference | 196.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 11.33% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBS has an Altman Z-Score of 1.01 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.01 |
| Piotroski F-Score | 5 |